About this trial
This study is being done to further develop a device, the mScan, to measure muscle health as compared to measurements of muscle health using MRI (magnetic resonance imaging). This device is held against the skin and uses Electrical Impedance Myography (EIM). EIM uses a very small, noninvasive (e.g. no needles), brief (about 6 seconds), and painless electrical current to measure the muscle. The investigators will look at how the mScan predicts the muscle measurements seen on MRI in people with and without muscle disease. The investigators hope that this can be used in the future as a quick, convenient and less time-consuming way than MRI to assess muscle health. This could be used to measure how well treatments for different muscle disorders are working over a period of time.
Eligibility criteria
Qualifiers
Ages 18-89
Evidence of a primary myopathic condition as determined by detailed chart review, including results of genetic testing, serological data, or previous muscle biopsy
Disqualifiers
Inability to lie flat or history of claustrophobia
>1+ lower extremity edema
Presence of multiple other pathologies affecting lower extremity muscles to be studied
Pregnancy
Trial design
Treatments tested in this trial
- Electrical Impedance Myography
Treatment groups
Sponsors and collaborators
Beth Israel Deaconess Medical Center
Lead sponsor
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Collaborator
Myolex, Inc
Collaborator